Annual CFI
$61.13 M
+$74.26 M+565.66%
31 December 2023
Summary:
Century Therapeutics annual cash flow from investing activities is currently $61.13 million, with the most recent change of +$74.26 million (+565.66%) on 31 December 2023. During the last 3 years, it has risen by +$83.89 million (+368.63%). IPSC annual CFI is now at all-time high.IPSC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
$39.20 M
+$73.06 M+215.75%
30 September 2024
Summary:
Century Therapeutics quarterly cash flow from investing activities is currently $39.20 million, with the most recent change of +$73.06 million (+215.75%) on 30 September 2024. Over the past year, it has increased by +$34.98 million (+829.55%). IPSC quarterly CFI is now at all-time high.IPSC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
$35.48 M
+$34.98 M+7038.63%
30 September 2024
Summary:
Century Therapeutics TTM cash flow from investing activities is currently $35.48 million, with the most recent change of +$34.98 million (+7038.63%) on 30 September 2024. Over the past year, it has dropped by -$2.78 million (-7.26%). IPSC TTM CFI is now -43.00% below its all-time high of $62.25 million, reached on 31 March 2023.IPSC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IPSC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +565.7% | +829.5% | -7.3% |
| 3 y3 years | +368.6% | +126.7% | +111.9% |
| 5 y5 years | - | - | - |
IPSC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +120.5% | at high | +126.7% | -43.0% | +111.9% |
| 5 y | 5 years | at high | +120.5% | at high | +126.7% | -43.0% | +111.9% |
| alltime | all time | at high | +120.5% | at high | +126.7% | -43.0% | +111.9% |
Century Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $39.20 M(-215.8%) | $35.48 M(+7038.6%) |
| June 2024 | - | -$33.86 M(-393.4%) | $497.00 K(-98.8%) |
| Mar 2024 | - | $11.54 M(-38.0%) | $41.34 M(-32.4%) |
| Dec 2023 | $61.13 M(-565.7%) | $18.60 M(+341.1%) | $61.13 M(+59.8%) |
| Sept 2023 | - | $4.22 M(-39.5%) | $38.26 M(-32.5%) |
| June 2023 | - | $6.97 M(-77.7%) | $56.70 M(-8.9%) |
| Mar 2023 | - | $31.34 M(-833.4%) | $62.25 M(-574.2%) |
| Dec 2022 | -$13.13 M | -$4.27 M(-118.9%) | -$13.13 M(-55.4%) |
| Sept 2022 | - | $22.66 M(+81.1%) | -$29.46 M(-85.2%) |
| June 2022 | - | $12.52 M(-128.4%) | -$199.18 M(-10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$44.04 M(+113.8%) | -$223.34 M(-25.1%) |
| Dec 2021 | -$298.34 M(+1211.0%) | -$20.60 M(-86.0%) | -$298.34 M(-0.1%) |
| Sept 2021 | - | -$147.05 M(+1162.5%) | -$298.52 M(+97.7%) |
| June 2021 | - | -$11.65 M(-90.2%) | -$150.99 M(+9.7%) |
| Mar 2021 | - | -$119.03 M(+472.8%) | -$137.61 M(+504.7%) |
| Dec 2020 | -$22.76 M(+14.7%) | -$20.78 M(-4465.8%) | -$22.76 M(+1051.7%) |
| Sept 2020 | - | $476.00 K(-72.4%) | -$1.98 M(-19.4%) |
| June 2020 | - | $1.73 M(-141.3%) | -$2.45 M(-41.3%) |
| Mar 2020 | - | -$4.18 M | -$4.18 M |
| Dec 2019 | -$19.83 M | - | - |
FAQ
- What is Century Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Century Therapeutics?
- What is Century Therapeutics annual CFI year-on-year change?
- What is Century Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Century Therapeutics?
- What is Century Therapeutics quarterly CFI year-on-year change?
- What is Century Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Century Therapeutics?
- What is Century Therapeutics TTM CFI year-on-year change?
What is Century Therapeutics annual cash flow from investing activities?
The current annual CFI of IPSC is $61.13 M
What is the all time high annual CFI for Century Therapeutics?
Century Therapeutics all-time high annual cash flow from investing activities is $61.13 M
What is Century Therapeutics annual CFI year-on-year change?
Over the past year, IPSC annual cash flow from investing activities has changed by +$74.26 M (+565.66%)
What is Century Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of IPSC is $39.20 M
What is the all time high quarterly CFI for Century Therapeutics?
Century Therapeutics all-time high quarterly cash flow from investing activities is $39.20 M
What is Century Therapeutics quarterly CFI year-on-year change?
Over the past year, IPSC quarterly cash flow from investing activities has changed by +$34.98 M (+829.55%)
What is Century Therapeutics TTM cash flow from investing activities?
The current TTM CFI of IPSC is $35.48 M
What is the all time high TTM CFI for Century Therapeutics?
Century Therapeutics all-time high TTM cash flow from investing activities is $62.25 M
What is Century Therapeutics TTM CFI year-on-year change?
Over the past year, IPSC TTM cash flow from investing activities has changed by -$2.78 M (-7.26%)